HealthyremTDCSNCT04749719
At Home Brain Stimulation Studies of Memory and Memory Awareness
A study testing remotely supervised transcranial direct current stimulation in people with Healthy, run by Brooklyn College of the City University of New York at 1 site in United States.
Trial summary
The main goal of this research is to determine the role of several brain regions in memory processes and cognitive functions. Participants will be remotely supervised via video chat while self-administering tDCS, a form of non-invasive brain stimulation. Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- remotely supervised transcranial direct current stimulation
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 36 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Apr 2021to 21 Aug 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- between the ages of 18-35
- normal or corrected to normal vision
- fluent in English and speaking English since age 5
- right handed
Who cannot join
- chronic skin disease or medical skin condition
- unhealed wound or open skin on the scalp, face, neck, or forehead
- metal or electrode implants (e.g., cochlear implants, pacemakers, metal plates, rods, or screws in their head; for complete detail, see the screening form)
- seizures or a family history of seizures, or are taking medications with a lowered seizure threshold
- pregnant or lactating
- any neurologic or psychiatric diseases
- certain hair styles (dreadlocks, cornrows, etc) or hair coverings (e.g., wigs, hajibs, etc that will not be removed; note that a request can be made for an experimenter of a specific gender)
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
Brooklyn College
Brooklyn, New York, 11210
Elizabeth Chua, PhD, 718-951-5000 ext. 6032, echua@brooklyn.cuny.edu
Casey Imperio, MS, (516) 610-0068, cimperio@gradcenter.cuny.edu
About this study
The main goal of this research is to determine the role of several brain regions in memory processes and cognitive functions. Participants will be remotely supervised via video chat while self-administering tDCS, a form of non-invasive brain stimulation. Before participating in the experiment, participants will be properly trained on use of the remote tDCS device and screened for eligibility. While using the tDCS device, participants will be engaging in tasks that assess different aspects of memory and executive functioning. By using remotely supervised tDCS while participants are completing these cognitive tasks, we will be able to make causal claims about the role of the targeted brain regions in different cognitive processes.
- Conditions
- Healthy
- Being tested
- remotely supervised transcranial direct current stimulation
- Keywords
- transcranial direct current stimulation, memory, metacognition, brain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
remotely supervised transcranial direct current stimulationDevice
Low levels of electrical current are applied across the scalp to induce small changes in brain activity. This is done using remote supervision.
| Study group | Role | What they receive |
|---|---|---|
| DLPFC stimulation | Experimental | F3-SO montage or OLE optimized with 2 mA stimulation for up to 30 min during memory and metamemory task. Receives: Device: remotely supervised transcranial direct current stimulation |
| Sham tDCS | Sham comparator | F3-SO montage or OLE optimized with sham stimulation for up to 30 min during memory and metamemory task. Receives: Device: remotely supervised transcranial direct current stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Memory performance
% Correct on the Memory Task
Measured: through study completion, an average of 4 weeks
Secondary outcomes (1)
Memory Confidence
Average % Confidence on the Memory Task
Measured: through study completion, an average of 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Feb 2021
- Study start15 Apr 2021
- Primary completion31 Aug 2022 (estimated)
- Study completion21 Aug 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Brooklyn College of the City University of New York
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of General Medical Sciences (NIGMS)
- Responsible party
- Principal investigator, Elizabeth Chua, Brooklyn College of the City University of New York
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04749719
- Sponsor's protocol ID
- 42037
- Other IDs
- SC3GM121192
- Acronym
- remTDCS
- Status last verified
- Apr 2021
- First submitted
- 1 Feb 2021
- Last updated
- 12 Jul 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jul 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- At Home Brain Stimulation Studies of Memory and Memory Awareness
- ClinicalTrials.gov ID
- NCT04749719
- Acronym / sponsor ID
- remTDCS / 42037
- Conditions
- Healthy
- Keywords
- transcranial direct current stimulation, memory, metacognition, brain
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Brooklyn College of the City University of New YorkUniversity, hospital or other
- Collaborators
- National Institute of General Medical Sciences (NIGMS)
- Study start
- 15 Apr 2021 (actual)
- Primary completion
- 31 Aug 2022 (estimated)
- Study completion
- 21 Aug 2023 (estimated)
- First posted
- 11 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main goal of this research is to determine the role of several brain regions in memory processes and cognitive functions. Participants will be remotely supervised via video chat while self-administering tDCS, a form of non-invasive brain stimulation. Before participating in the experiment, participants will be properly trained on use of the remote tDCS device and screened for eligibility. While using the tDCS device, participants will be engaging in tasks that assess different aspects of memory and executive functioning. By using remotely supervised tDCS while participants are completing these cognitive tasks, we will be able to make causal claims about the role of the targeted brain regions in different cognitive processes.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| DLPFC stimulation | Experimental | Device: remotely supervised transcranial direct current stimulationF3-SO montage or OLE optimized with 2 mA stimulation for up to 30 min during memory and metamemory task. |
| Sham tDCS | Sham comparator | Device: remotely supervised transcranial direct current stimulationF3-SO montage or OLE optimized with sham stimulation for up to 30 min during memory and metamemory task. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- between the ages of 18-35
- normal or corrected to normal vision
- fluent in English and speaking English since age 5
- right handed
Key exclusion criteria (7 listed)
- chronic skin disease or medical skin condition
- unhealed wound or open skin on the scalp, face, neck, or forehead
- metal or electrode implants (e.g., cochlear implants, pacemakers, metal plates, rods, or screws in their head; for complete detail, see the screening form)
- seizures or a family history of seizures, or are taking medications with a lowered seizure threshold
- pregnant or lactating
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| remotely supervised transcranial direct current stimulationLow levels of electrical current are applied across the scalp to induce small changes in brain activity. This is done using remote supervision. | Device | DLPFC stimulation, Sham tDCS |
Primary outcome
Memory performance
Time frame: through study completion, an average of 4 weeks
% Correct on the Memory Task
1 secondary outcome
Memory Confidence
Time frame: through study completion, an average of 4 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jul 2021.
- Individual participant dataSharing planned: No
Related trials for Healthy
RecruitingObservational study
Studies of Blood Flow to the Brain During Thought
Healthy Volunteer
Enrolling by invitationObservational study
Screening for Hematology Branch Protocols
Hematologic Disease and Disorders, Donors
Enrolling by invitationObservational study
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Neoplasms, Hematologic Neoplasms
Enrolling by invitationObservational study
Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick
Healthy Donors
RecruitingObservational study
Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Healthy Volunteers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing remotely supervised transcranial direct current stimulation in people with Healthy, run by Brooklyn College of the City University of New York at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 12 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact ELIZABETH CHUA, PHD (7189515000 ext. 6032, echua@brooklyn.cuny.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Memory performance (time frame: through study completion, an average of 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2021; AzTrials last refreshed its copy on 6 Nov 2026.